Piershale Financial Group’s Boston Scientific BSX Stock Holding History

Piershale Financial Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$5.41K	Hold	100	–	–	﹤0.01%	157
2023 Q1	$5K	Hold	100	–	–	﹤0.01%	170
2022 Q4	$4.63K	Buy	+100	New	+$4.33K	﹤0.01%	185
2016 Q4	–	Sell	-100	Closed	-$2K	–	36
2016 Q3	$2K	Hold	100	–	–	﹤0.01%	132
2016 Q2	$2K	Hold	100	–	–	﹤0.01%	121
2016 Q1	$2K	Hold	100	–	–	﹤0.01%	119
2015 Q4	$2K	Hold	100	–	–	﹤0.01%	170
2015 Q3	$2K	Hold	100	–	–	﹤0.01%	117
2015 Q2	$2K	Hold	100	–	–	﹤0.01%	98
2015 Q1	$2K	Hold	100	–	–	﹤0.01%	115
2014 Q4	$1K	Hold	100	–	–	﹤0.01%	135
2014 Q3	$1K	Hold	100	–	–	﹤0.01%	125
2014 Q2	$1K	Hold	100	–	–	﹤0.01%	143
2014 Q1	$1K	Hold	100	–	–	﹤0.01%	120
2013 Q4	$1K	Hold	100	–	–	﹤0.01%	123
2013 Q3	$1K	Hold	100	–	–	﹤0.01%	97
2013 Q2	$1K	Buy	+100	New	+$848	﹤0.01%	84

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Piershale Financial Group's BSX Position: Q2 2023 in Review

Piershale Financial Group held its Boston Scientific (BSX) position steady in Q2 2023 at 100 shares worth $5.41K. The position accounts for ﹤0.01% of the portfolio, ranked #157.

Piershale Financial Group first reported a position in BSX in Q2 2013 and has held it in 17 quarters since. 1,067 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

Piershale Financial Group held 100 shares of Boston Scientific worth $5.41K as of Q2 2023.
Piershale Financial Group left its Boston Scientific share count unchanged in Q2 2023.
Boston Scientific made up ﹤0.01% of Piershale Financial Group's portfolio in Q2 2023, its #157 holding.
Piershale Financial Group first reported a position in Boston Scientific in Q2 2013 and has held it in 17 quarters since.
1,067 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Piershale Financial Group's 13F filing for Q2 2023, filed 6 Jul 2023.